Pseudomonas aeruginosa in chronic obstructive pulmonary disease

Am J Respir Crit Care Med. 2008 Apr 15;177(8):853-60. doi: 10.1164/rccm.200709-1413OC. Epub 2008 Jan 17.


Rationale: Pseudomonas aeruginosa is isolated from adults with chronic obstructive pulmonary disease (COPD) in cross-sectional studies. However, patterns of carriage and the role of P. aeruginosa in COPD are unknown.

Objectives: To elucidate carriage patterns, phenotypes of strains, clinical manifestations, and the antibody response to P. aeruginosa in COPD.

Methods: A prospective study of adults with COPD was conducted. Isolates of P. aeruginosa were subjected to genotypic and phenotypic analysis. Sputum samples were studied for P. aeruginosa DNA, and immune responses were assayed.

Measurements and main results: We analyzed longitudinal clinical data, sputum cultures, pulsed-field gel electrophoresis of bacterial DNA, polymerase chain reaction of sputum, and immunoblot assays of serum. Fifty-seven episodes of acquisition of strains of P. aeruginosa were observed in 39 of 126 patients over 10 years. Acquisition of a new strain was associated with exacerbation. Thirty-one episodes of carriage were followed by clearance of the strain; 16 were of short (<1 mo) duration. Thirteen strains demonstrated persistence, and 13 strains were of indeterminate duration. Six strains were mucoid and were more likely to persist than nonmucoid strains (P = 0.005). Antibody responses developed in 53.8% of persistent carriage and in only 9.7% of short-term carriage episodes (P = 0.003). Antibiotics did not account for clearance.

Conclusions: Two distinct patterns of carriage by P. aeruginosa were observed: (1) short-term colonization followed by clearance and (2) long-term persistence. Mucoid strains showed persistence. Acquisition of P. aeruginosa is associated with the occurrence of an exacerbation. Serum antibody responses do not mediate clearance of P. aeruginosa.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Carrier State / immunology
  • Carrier State / microbiology*
  • Electrophoresis, Gel, Pulsed-Field
  • Genotype
  • Hospitals, Veterans
  • Humans
  • Longitudinal Studies
  • Middle Aged
  • Phenotype
  • Pseudomonas Infections / classification
  • Pseudomonas Infections / physiopathology*
  • Pseudomonas aeruginosa / classification
  • Pseudomonas aeruginosa / immunology
  • Pseudomonas aeruginosa / pathogenicity*
  • Pulmonary Disease, Chronic Obstructive / microbiology*
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Sputum / microbiology*